109 related articles for article (PubMed ID: 6563035)
1. Antimicrobial tolerance in group C and group G streptococci.
Rolston KV; Chandrasekar PH; LeFrock JL
J Antimicrob Chemother; 1984 Apr; 13(4):389-92. PubMed ID: 6563035
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
Marton A; Major P
Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
[TBL] [Abstract][Full Text] [Related]
3. Antistreptococcal activity of Sch 34343, a new penem antibiotic.
Yu PK; Washington JA
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():67-71. PubMed ID: 3928578
[TBL] [Abstract][Full Text] [Related]
4. Activity of teicoplanin compared with vancomycin alone, and combined with gentamicin, against penicillin tolerant viridans streptococci and enterococci causing endocarditis.
Shanson DC; Tadayon M
J Hosp Infect; 1986 Mar; 7 Suppl A():65-72. PubMed ID: 2871099
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives.
Jacobs MR; Kelly F; Speck WT
Antimicrob Agents Chemother; 1982 Nov; 22(5):897-900. PubMed ID: 6758692
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis.
Teng LJ; Hsueh PR; Chen YC; Ho SW; Luh KT
J Antimicrob Chemother; 1998 Jun; 41(6):621-7. PubMed ID: 9687100
[TBL] [Abstract][Full Text] [Related]
7. Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae.
Bañón Arias R; García López M; Pinedo Sánchez A
J Chemother; 2001 Oct; 13(5):535-40. PubMed ID: 11760218
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of group G streptococci to ten antimicrobial agents with broad gram-positive spectra.
Bayer AS; Lam K
Clin Ther; 1983; 5(4):391-7. PubMed ID: 6871922
[TBL] [Abstract][Full Text] [Related]
10. Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.
Watanakunakorn C; Glotzbecker C
J Med Microbiol; 1977 Feb; 10(1):133-8. PubMed ID: 584243
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of linezolid, meropenem, and quinupristin-dalfopristin against group C and G streptococci, including vancomycin-tolerant isolates.
Zaoutis T; Moore LS; Furness K; Klein JD
Antimicrob Agents Chemother; 2001 Jul; 45(7):1952-4. PubMed ID: 11408207
[TBL] [Abstract][Full Text] [Related]
12. In vitro bactericidal synergy of gentamicin combined with penicillin G, vancomycin, or cefotaxime against group G streptococci.
Lam K; Bayer AS
Antimicrob Agents Chemother; 1984 Aug; 26(2):260-2. PubMed ID: 6091537
[TBL] [Abstract][Full Text] [Related]
13. Group G Streptococci: susceptibility patterns and the effect of the inoculum size and growth phase on the bactericidal activity of penicillin.
Libertin CR; Leal F; Stein DS
Diagn Microbiol Infect Dis; 1988 Jan; 9(1):33-40. PubMed ID: 3370929
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of some streptococci strains of anginosus group isolated from oral and maxillofacial infections.
Băncescu G; Skaug N; Dumitriu S; Băncescu A
Roum Arch Microbiol Immunol; 1999; 58(1):57-63. PubMed ID: 11845446
[TBL] [Abstract][Full Text] [Related]
15. Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics.
Liñares J; Perez JL; Garau J; Murgui L; Martín R
J Antimicrob Chemother; 1984 Apr; 13(4):353-9. PubMed ID: 6609919
[TBL] [Abstract][Full Text] [Related]
16. Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci.
Cercenado E; Díaz MD; Sánchez-Carrillo C; Vicente T; Bernaldo de Quirós JC
Antimicrob Agents Chemother; 1995 Dec; 39(12):2816-8. PubMed ID: 8593029
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic susceptibilities of group C and group G streptococci isolated from patients with invasive infections: evidence of vancomycin tolerance among group G serotypes.
Zaoutis T; Schneider B; Steele Moore L; Klein JD
J Clin Microbiol; 1999 Oct; 37(10):3380-3. PubMed ID: 10488212
[TBL] [Abstract][Full Text] [Related]
18. In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin.
Skov R; Christensen JJ; Korner B; Frimodt-Møller N; Espersen F
J Antimicrob Chemother; 2001 Nov; 48(5):653-8. PubMed ID: 11679554
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of contemporary beta-lactam drugs tested against viridans group and beta-haemolytic streptococci.
Pfaller MA; Jones RN
Diagn Microbiol Infect Dis; 1997 Apr; 27(4):151-4. PubMed ID: 9154412
[TBL] [Abstract][Full Text] [Related]
20. Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.
Desbiolles N; Piroth L; Lequeu C; Neuwirth C; Portier H; Chavanet P
Antimicrob Agents Chemother; 2001 Dec; 45(12):3328-33. PubMed ID: 11709304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
